Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-Methylimidazole | HCID 12749 | — |
| Reactant | HCID 70345157 | HCID 70345157 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 70345096 | HCID 70345096 | 47.3% |
Reaction Steps
Trans-7-chloro-5-(1 -naphthyl)-1 -(4-iodobutyl)-2-oxo-1,2,3,5-tetrahydro-4,1 -benzoxazepine-3-acetonitrile (575 mg, 1.06 mmol), 2-methylimidazole (87 mg, 1.06 mmol) and potassium carbonate (146 mg, 1.06 mmol) were dissolved in DMF (5 ml) and the resulting solution stirred at 25° C. for 72 hours. Ethyl acetate was added and the solution washed with water (4×). The organic layer was dried (MgSO4), concentrated under reduced pressure and purified by flash column chromatography (ethyl acetate/diethylamine 95:5) to give the title compound (250 mg, 47%) as a colorless foam.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05965553 |
|---|
| Source dataset | uspto-grants-1999_10 |
|---|
| ORD ID | ord-e6d6cf4a172747488bf7ae8e6a161e0e |
|---|
| Source note | uspto-grants-1999_10 |
|---|